{
    "nct_id": "NCT04459273",
    "official_title": "PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation",
    "inclusion_criteria": "* Patients with the following cancer types:\n\n  * Brain cancer\n  * Bladder cancer\n  * Urothelial cancer\n  * Testicular cancer\n  * Skin cancer\n  * Thyroid cancer\n  * Hepatocellular carcinoma\n  * Cholangiocarcinoma\n  * Thymus cancer\n  * Pleural cancer\n  * Cervical cancer\n  * Adrenal cancer\n  * Neuroendocrine tumors\n  * Hematologic cancer\n  * Cancer of Unkown Primary\n* Patients who are scheduled to undergo surgical resection or tissue biopsy of the primary tumor and/or metastasis\n* Patients are â‰¥ 18 years old at the time of the radiotracer administration.\n* Patient can provide written informed consent\n* Patient is able to remain still for duration of imaging procedure (up to one hour)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patient is pregnant or nursing\n* Patients with any new cancer therapy between the baseline PET/CT and the investigational FAPI PET/CT\n* Patient has underlying disease which, based on the judgment of the investigator, might interfere with the collection of high quality data",
    "miscellaneous_criteria": ""
}